USP 29 National Formula 24 (USP 29-NF 24)

The “USP 29 National Formulary 24 (USP 29-NF 24)” standard, published by the United States Pharmacopoeia (USP), refers to the 29th edition of the United States Pharmacopoeia (USP), a globally recognized compilation that sets quality standards for drugs, excipients, and nutritional supplements. It is typically published alongside the national formulary (NF), forming a combined USP-NF standard.

USP 29 primarily includes the following:

• Monographs: Contain detailed specifications for the following:
• Active pharmaceutical ingredients (APIs)
• Finished dosage forms
• Detailed specifications for individual drugs and substances.
• Tests, analyses, and acceptance criteria.

Each monograph includes the following:

• Identification tests
• Analysis methods
• Impurity limits
• Accept conditions
• General sections: Provides standardized test methods and procedures such as the following:
• <905> Uniformity of dosage units
• Standardized test methods (e.g., dissolution, sterility, microbiological)
• Guidance for laboratory procedures

Key sections of USP 29, such as <905>, have been revised, and the acceptance criteria for dosage uniformity have been updated.

• General notices: All monographs and tests explain how to interpret and apply USP standards.

USP 29 includes several significant updates compared to previous versions:

• Harmonization with international standards
• Revised content uniformity requirements.
• Analytical methods improved for accuracy and repeatability.
• Updated impurity limits and test procedures.
• Increased focus on the statistical evaluation of quality tests.

These changes have helped align the USP with global drug regulatory expectations.

The importance of USP 29 in the pharmaceutical industry is as follows:

• Compliance with regulations: USP standards are used as a reference in US law. Products that do not comply with USP specifications are considered fraudulent.
• Quality assurance: USP 29 provides verified methods that ensure:
• Consistency across parties
• Reliable analytical tests
• Product safety and efficacy
• Global acceptance: Many countries adopt or use USP standards as a reference. This makes USP 29 a globally influential document.

USP 29 is used in the following areas:

• Pharmaceutical manufacturing (quality control and release testing)
• Pharmaceutical R&D
• Applications for legal regulations
• Pharmacies
• Academic research

Typical tests based on USP 29 include:

• Analysis (e.g., 90-110% labeling claim)
• dissolution test
• Fragmentation test
• Content homogeneity

USP 29 remains relevant for the following:

• Legacy product validation
• Historical comparative studies
• Legal documentation referring to outdated standards

In conclusion, USP 29 represents a critical step in the evolution of pharmaceutical quality standards. By establishing clear, scientifically based requirements, it has helped ensure that medicines are safe, effective, and consistent. Harmonization efforts and updated testing methodologies have made significant contributions to modern pharmaceutical quality systems.

USP 29 is a landmark document in the history of pharmaceutical standardization. Often cited alongside National Formulary 24 (NF 24), this edition marked a significant shift towards international harmonization and more rigorous statistical controls in pharmaceutical production.

The primary goal of USP 29 is to align U.S. standards with the International Council for Harmonisation (ICH) and to ensure that a drug manufactured in one country can meet the quality expectations of another country without the need for unnecessary testing.

One of the most significant changes in USP 29 is the revision of section <905> Uniformity of Dosage Units. This update introduced a more advanced “acceptance limit” calculation. Instead of simple pass/fail limits based on individual tablet weights, manufacturers are now required to use statistical methods to ensure the active ingredient is distributed consistently throughout the entire batch. This shift has forced the industry to adopt new mathematical models and software for generating acceptance limit tables.

USP 29, “General Section <711> Dissolution,” has been formally adopted as a harmonized text. This is the result of a major collaborative effort between the pharmacopoeias of the United States, Europe, and Japan. By standardizing equipment (such as baskets and paddles) and procedures for how drugs are broken down in the body, USP 29 has helped reduce the regulatory burden on global pharmaceutical companies and enable a more universal testing protocol.

USP 29 also expanded the catalog of reference standards. These are the physical chemicals provided by the USP convention that manufacturers use to calibrate their equipment. At the time of its publication, USP 29 consisted of over 3.500 pages of monographs covering everything from basic aspirin to complex biotechnological proteins.

USP 29 has gone through many editions, but it continues to be frequently referenced in academic literature and older stability studies.

USP 29 formed the basis for the following:

• Regulatory compliance: The USP's legal authority has been strengthened under the federal Food, Drug, and Cosmetic Act.
• Public safety: By tightening regulations on how much flexibility manufacturers are allowed in dosage consistency, it has directly reduced the risk of patients receiving inadequate or toxic doses.
• Global trade: It paved the way for a "single quality standard" vision where patients can trust the medicine in the bottle regardless of where it was manufactured. Because the USP is updated annually and additions are made throughout the year, current practitioners should always refer to the latest version of the USP-NF for active legal requirements, as many sections from the USP 29 era have since been further improved or amended.

In short, USP 29 is the 29th Revision of the United States Pharmacopoeia (USP), a globally recognized compilation of standards for drugs, pharmaceutical ingredients, and related products. This edition was released in 2005 and contains thousands of pages of pharmaceutical standards.

In general, USP standards ensure that products meet the following requirements:

• Identity (correct item)
• Power (correct dosage)
• Quality
• Purity

These standards are widely used worldwide and are often enforced by regulatory authorities such as the FDA.

USP 29 includes the following:

• Thousands of drug monographs
• Formal analytical methods
• Features for:
• Raw Materials
• Finished pharmaceutical products
• Excipients

It also includes commonly used test sections:

• dissolution test
• Sterility test
• Homogeneity of dosage units

These methods are critical for ensuring consistent drug performance and safety.

USP 29 is used by:

• Pharmaceutical manufacturers
• Quality control laboratories
• Regulatory bodies
• Academic researchers

USP 29 is important in the following areas:

• Drug development
• Quality control tests
• Validation of analytical methods
• Comparison of generic and branded drugs.

For many years, our organization, with its competent and experienced team, has been understanding the needs of its clients, providing the advanced testing services they require, and assisting them in the establishment, implementation, and improvement of management systems. Within this framework, we also provide testing services compliant with USP 29 certification.